查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1957835

2026年全球皮下給藥裝置市場報告

Subcutaneous Drug Delivery Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，皮下給藥裝置的市場規模顯著成長。預計該市場將從2025年的297.7億美元成長到2026年的320.3億美元，複合年成長率（CAGR）為7.6%。過去幾年的成長歸因於多種因素，例如糖尿病和慢性病盛行率的上升、胰島素筆和筆針使用量的增加、醫院和診所基礎設施的擴建、先進給藥技術的應用有限以及人們對皮下給藥認知的提高。

預計未來幾年皮下給藥裝置市場將維持強勁成長，2030年市場規模將達到424.2億美元，複合年成長率（CAGR）為7.3%。預測期內的成長要素包括生物製藥和腫瘤治療的拓展、智慧自動注射器的普及、居家醫療環境的擴展、植入式幫浦技術的進步以及對以患者為中心的給藥解決方案日益成長的需求。預測期內的主要趨勢包括自動注射器和智慧注射裝置的普及、對家庭和自我管理療法的偏好日益增強、對微創給藥方法的需求不斷成長、生物製藥和生物類似藥給藥應用的拓展，以及透過人性化裝置設計提高患者依從性。

預計未來幾年，糖尿病和心血管疾病（CVD）盛行率的不斷上升將推動皮下給藥裝置市場的擴張。導致糖尿病和心血管疾病發生率上升的因素包括人口老化、不良飲食習慣、久坐的生活方式、肥胖、社會經濟差距、壓力、環境因素以及預防性醫療保健服務取得受限。皮下給藥裝置廣泛應用於糖尿病管理（用於注射胰島素和其他藥物以控制血糖）和心血管護理（用於注射抗凝血劑和降脂藥等藥物），為長期疾病的管理提供了一種便捷且可控的方法。例如，根據美國疾病管制與預防中心（CDC）的數據，截至2024年10月，2023年心血管疾病導致919,032人死亡，約佔總死亡人數的三分之一。因此，糖尿病和心血管疾病負擔的加重正在推動皮下給藥裝置市場的成長。

皮下給藥裝置市場的主要企業正致力於開發先進技術，例如微型數位液體流量感測器，以實現大容量注射器的精確可自訂流量控制，從而提高皮下給藥的準確性和安全性。微型數位液體流量感測器是一種緊湊型組件，可在小規模應用中精確測量液體流量，並提供數位輸出以進行精確監控和控制。例如，2024年5月，瑞士環境和流量感測器解決方案供應商Sensirion AG發布了SLD3x系列感測器平台。此產品線包含高精度數位液體流量感測器，具有可定製配置，提供精確流量測量、堵塞檢測、在線連續氣泡檢測和液體溫度監測等功能。這些緊湊型感測器非常適合大規模醫療設備生產，有助於提高皮下給藥的劑量控制精度和病患安全性。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球皮下給藥裝置市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施、互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 自動注射器和智慧注射裝置的應用日益普及
    • 人們越來越傾向於選擇居家和自我治療方式
    • 對微創藥物傳遞方法的需求日益成長
    • 拓展生物製藥和生物類似藥製劑的藥物傳遞應用
    • 透過人性化的設備設計提高患者依從性

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 居家醫療設施
  • 門診手術中心
  • 專業醫療中心
  • 診斷和治療中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球皮下給藥裝置市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球皮下給藥裝置市場規模、對比及成長率分析
  • 全球皮下給藥裝置市場表現：規模與成長，2020-2025年
  • 全球皮下給藥裝置市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依產品類型
  • 胰島素筆、筆針、注射筆、自動注射器、植入式泵
  • 透過使用
  • 糖尿病、不孕症治療、腫瘤學
  • 最終用戶
  • 醫院和診所、居家醫療環境、門診手術中心
  • 按類型細分：胰島素筆
  • 拋棄式胰島素筆，可重覆使用胰島素筆
  • 按類型細分：針頭式注射器
  • 標準注射筆針，安全注射筆針
  • 按類型細分：注射筆
  • 一次性注射筆，可重複使用注射筆
  • 按類型細分：自動注射器
  • 手動自動注射器，智慧型自動注射器
  • 按類型細分：嵌入式泵
  • 胰島素泵，藥物輸注泵

第10章 區域與國別分析

  • 全球皮下給藥裝置市場：依地區分類，歷史資料及預測，2020-2025年，2025-2030年預測，2035年預測
  • 全球皮下給藥裝置市場：依國家分類，實際值及預測值，2020-2025年、2025-2030年預測值、2035年預測值

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 皮下給藥裝置市場：競爭格局及市佔率（2024年）
  • 皮下給藥裝置市場：公司估值矩陣
  • 皮下給藥裝置市場：公司概況
    • Pfizer Inc.
    • Sanofi SA
    • Roche Holdings Inc.
    • Medtronic plc
    • Eli Lilly and Company

第37章 其他大型企業和創新企業

  • Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年皮下給藥裝置市場：提供新機會的國家
  • 2030年皮下給藥裝置市場：充滿新機會的細分市場
  • 皮下給藥裝置市場2030年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH6MSDDD01_G26Q1

Subcutaneous drug delivery devices are medical instruments developed to deliver medications directly into the subcutaneous tissue, which is the layer of fat and connective tissue located just beneath the skin. These devices are commonly used to administer a range of medications, including insulin, hormones, and biologics, offering a convenient and minimally invasive approach to drug delivery.

The primary product types of subcutaneous drug delivery devices include insulin pens, pen needles, injector pens, auto-injectors, and implantable pumps. Insulin pens are portable devices designed for the accurate and convenient delivery of insulin in diabetes care, enabling users to easily measure and inject prescribed doses. These devices are applied in various therapeutic areas such as diabetes, fertility, and oncology, and are used by multiple end users including hospitals and clinics, homecare settings, and ambulatory surgical centers.

Tariffs have impacted the subcutaneous drug delivery devices market by increasing the cost of imported components such as precision needles, electronic modules, and medical-grade plastics. Product segments including smart auto-injectors and implantable pumps are most affected, particularly in Asia-Pacific and Europe where manufacturing relies on cross-border supply chains. These cost pressures have led to higher device prices and delayed adoption in some regions. However, tariffs have also encouraged local manufacturing, supply chain diversification, and innovation in cost-effective subcutaneous delivery technologies.

The subcutaneous drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides subcutaneous drug delivery devices market statistics, including subcutaneous drug delivery devices industry global market size, regional shares, competitors with a subcutaneous drug delivery devices market share, detailed subcutaneous drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the subcutaneous drug delivery devices industry. This subcutaneous drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The subcutaneous drug delivery devices market size has grown strongly in recent years. It will grow from $29.77 billion in 2025 to $32.03 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising prevalence of diabetes and chronic diseases, increasing use of insulin pens and pen needles, growing hospital and clinic infrastructure, limited availability of advanced delivery technologies, increasing awareness of subcutaneous drug administration.

The subcutaneous drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $42.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in biologics and oncology therapies, increasing adoption of smart auto-injectors, expansion of homecare settings, technological advancements in implantable pumps, rising demand for patient-centric drug delivery solutions. Major trends in the forecast period include rising adoption of auto-injectors and smart injection devices, growing preference for home-based and self-administration therapies, increasing demand for minimally invasive drug delivery methods, expansion of biologic and biosimilar drug delivery applications, improved patient compliance through user-friendly device designs.

The growing prevalence of diabetes and cardiovascular diseases (CVD) is expected to drive the expansion of the subcutaneous drug delivery devices market in the coming years. The rise in diabetes and cardiovascular conditions is influenced by factors such as aging populations, poor dietary habits, sedentary lifestyles, obesity, socioeconomic disparities, stress, environmental influences, and limited access to preventive healthcare services. Subcutaneous drug delivery devices are widely used in diabetes management to administer insulin and other therapies for glycemic control, and in cardiovascular care to deliver medications such as anticoagulants or lipid-lowering agents, offering a convenient and controlled approach to managing these long-term conditions. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based federal agency, cardiovascular disease accounted for 919,032 deaths in 2023, representing nearly one in every three deaths. Consequently, the increasing burden of diabetes and cardiovascular diseases is contributing to the growth of the subcutaneous drug delivery devices market.

Major companies operating in the subcutaneous drug delivery devices market are concentrating on the development of advanced technologies, such as miniature digital liquid flow sensors, to improve the accuracy and safety of subcutaneous drug administration by enabling precise and customizable flow control for large-volume injectors. Miniature digital liquid flow sensors are compact components that accurately measure liquid flow rates in small-scale applications and provide digital outputs for precise monitoring and regulation. For instance, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensor solutions, introduced the SLD3x series sensor platform. This product line includes highly accurate digital liquid flow sensors with customizable configurations, offering features such as precise flow measurement, occlusion detection, in-line air bubble detection, and liquid temperature monitoring. These compact sensors are well suited for large-scale medical device manufacturing, supporting accurate dosing and enhanced patient safety in subcutaneous drug delivery.

In November 2025, Halozyme Therapeutics, a US-based biopharmaceutical company focused on innovative drug delivery technologies, completed the acquisition of Elektrofi for an undisclosed amount. Through this acquisition, Halozyme seeks to broaden its drug delivery technology portfolio, strengthen its capabilities in developing high-concentration, ready-to-use injectable biologics, and reinforce its position in the rapidly expanding market for patient-friendly subcutaneous delivery solutions. Elektrofi is a US-based biotechnology company that specializes in subcutaneous drug delivery devices.

Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

North America was the largest region in the subcutaneous drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the subcutaneous drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The subcutaneous drug delivery devices market consists of sales of needles, cartridges, and reservoirs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Subcutaneous Drug Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses subcutaneous drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for subcutaneous drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The subcutaneous drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Insulin Pens; Pen Needles; Injector Pens; Auto-Injectors; Implantable Pumps
  • 2) By Application: Diabetes; Fertility; Oncology
  • 3) By End-User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Insulin Pens: Disposable Insulin Pens; Reusable Insulin Pens
  • 2) By Pen Needles: Standard Pen Needles; Safety Pen Needles
  • 3) By Injector Pens: Disposable Injector Pens; Reusable Injector Pens
  • 4) By Auto-Injectors: Manual Auto-Injectors; Smart Auto-Injectors
  • 5) By Implantable Pumps: Insulin Pumps; Drug Infusion Pumps
  • Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Roche Holdings Inc.; Medtronic plc; Eli Lilly and Company; Amgen Inc.; Novo Nordisk A/S; Becton Dickinson and Company; West Pharmaceutical Services Inc.; Gerresheimer AG; Insulet Corporation; SHL Medical AG; Tandem Diabetes Care Inc.; Ypsomed Holding AG; Nemera; Elcam Medical Ltd.; Owen Mumford Ltd.; Haselmeier GmbH; Sensile Medical AG; Enable Injections Inc.; Unilife Corporation; PharmaJet; Oval Medical Technologies Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Subcutaneous Drug Delivery Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Subcutaneous Drug Delivery Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Subcutaneous Drug Delivery Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Subcutaneous Drug Delivery Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Auto-Injectors And Smart Injection Devices
    • 4.2.2 Growing Preference For Home-Based And Self-Administration Therapies
    • 4.2.3 Increasing Demand For Minimally Invasive Drug Delivery Methods
    • 4.2.4 Expansion Of Biologic And Biosimilar Drug Delivery Applications
    • 4.2.5 Improved Patient Compliance Through User-Friendly Device Designs

5. Subcutaneous Drug Delivery Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Homecare Settings
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Care Centers
  • 5.5 Diagnostic And Treatment Centers

6. Subcutaneous Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Subcutaneous Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Subcutaneous Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Subcutaneous Drug Delivery Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Subcutaneous Drug Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Subcutaneous Drug Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Subcutaneous Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Subcutaneous Drug Delivery Devices Market Segmentation

  • 9.1. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
  • 9.2. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diabetes, Fertility, Oncology
  • 9.3. Global Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
  • 9.4. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Insulin Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Insulin Pens, Reusable Insulin Pens
  • 9.5. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Pen Needles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard Pen Needles, Safety Pen Needles
  • 9.6. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Injector Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Injector Pens, Reusable Injector Pens
  • 9.7. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Auto-Injectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Manual Auto-Injectors, Smart Auto-Injectors
  • 9.8. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Implantable Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insulin Pumps, Drug Infusion Pumps

10. Subcutaneous Drug Delivery Devices Market Regional And Country Analysis

  • 10.1. Global Subcutaneous Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Subcutaneous Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Subcutaneous Drug Delivery Devices Market

  • 11.1. Asia-Pacific Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Subcutaneous Drug Delivery Devices Market

  • 12.1. China Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Subcutaneous Drug Delivery Devices Market

  • 13.1. India Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Subcutaneous Drug Delivery Devices Market

  • 14.1. Japan Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Subcutaneous Drug Delivery Devices Market

  • 15.1. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Subcutaneous Drug Delivery Devices Market

  • 16.1. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Subcutaneous Drug Delivery Devices Market

  • 17.1. South Korea Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Subcutaneous Drug Delivery Devices Market

  • 18.1. Taiwan Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Subcutaneous Drug Delivery Devices Market

  • 19.1. South East Asia Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Subcutaneous Drug Delivery Devices Market

  • 20.1. Western Europe Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Subcutaneous Drug Delivery Devices Market

  • 21.1. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Subcutaneous Drug Delivery Devices Market

  • 22.1. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Subcutaneous Drug Delivery Devices Market

  • 23.1. France Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Subcutaneous Drug Delivery Devices Market

  • 24.1. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Subcutaneous Drug Delivery Devices Market

  • 25.1. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Subcutaneous Drug Delivery Devices Market

  • 26.1. Eastern Europe Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Subcutaneous Drug Delivery Devices Market

  • 27.1. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Subcutaneous Drug Delivery Devices Market

  • 28.1. North America Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Subcutaneous Drug Delivery Devices Market

  • 29.1. USA Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Subcutaneous Drug Delivery Devices Market

  • 30.1. Canada Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Subcutaneous Drug Delivery Devices Market

  • 31.1. South America Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Subcutaneous Drug Delivery Devices Market

  • 32.1. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Subcutaneous Drug Delivery Devices Market

  • 33.1. Middle East Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Subcutaneous Drug Delivery Devices Market

  • 34.1. Africa Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Subcutaneous Drug Delivery Devices Market Regulatory and Investment Landscape

36. Subcutaneous Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 36.1. Subcutaneous Drug Delivery Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Subcutaneous Drug Delivery Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Subcutaneous Drug Delivery Devices Market Company Profiles
    • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Roche Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

37. Subcutaneous Drug Delivery Devices Market Other Major And Innovative Companies

  • Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc.

38. Global Subcutaneous Drug Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Subcutaneous Drug Delivery Devices Market

40. Subcutaneous Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Subcutaneous Drug Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Subcutaneous Drug Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Subcutaneous Drug Delivery Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer